Safety and Efficacy of Xalkori ROS1

Clinical trial NCT03375242 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03375242
Sponsor: Pfizer
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer

Start date: 2017-10-25
Primary completion: 2026-11-06
Enrollment: 97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.